Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Behcet's disease.

M Suzuki Kurokawa1, N Suzuki

  • 1Department of Immunology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8511, Japan. n3suzuki@marianna-u.ac.jp

Clinical and Experimental Medicine
|December 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful collection of peripheral blood stem cells from an infant with acute lymphoblastic leukemia using the Haemonetics V50.

Acta paediatrica Japonica : Overseas edition·1992
Same author

[The first cholera case diagnosed early in the clinical laboratory by DNA probe method].

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases·1992
Same author

Rice dwarf phytoreovirus segment S12 transcript is tricistronic in vitro.

Virology·1992
Same author

Endothelin-1 mediates regional blood flow during and after pulmonary operations.

The Journal of thoracic and cardiovascular surgery·1992
Same author

Changes of splenic lymphocyte subpopulation in mice inoculated with Babesia microti and Babesia rodhaini.

The Journal of veterinary medical science·1992
Same author

[A case of mitral valve replacement in the first three months of life for congenital mitral valve regurgitation].

[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai·1992
Same journal

Silibinin promotes hepatocyte proliferation through PINK1/Parkin-mediated mitophagy to alleviate acetaminophen-induced liver injury.

Clinical and experimental medicine·2026
Same journal

Serum GRP78 as a potential biomarker for early liver injury and active fibrogenesis in alcohol-associated liver disease.

Clinical and experimental medicine·2026
Same journal

Beyond polarization: a receptor-centered framework for macrophage function and therapy in skin diseases.

Clinical and experimental medicine·2026
Same journal

UBA2: the gatekeeper of the sumoylation pathway and its multifaceted roles in human diseases and therapeutic prospects.

Clinical and experimental medicine·2026
Same journal

Clonal Metamorphosis: Deconstructing MPN Evolution with Single-Cell and Spatial Multi-Omics.

Clinical and experimental medicine·2026
Same journal

Identifying coagulation-related biomarkers in steroid-induced osteonecrosis of the femoral head: implications for early diagnosis and treatment.

Clinical and experimental medicine·2026
See all related articles

Behcet

Area of Science:

  • Rheumatology and Immunology
  • Systemic Inflammatory Disorders

Background:

  • Behcet's disease (BD) is a rare systemic inflammatory disorder characterized by recurrent oral ulcers, uveitis, skin, and genital lesions.
  • Geographically, BD prevalence is higher along the Silk Road, with lower incidence in East Asia and the Mediterranean compared to the UK and North America.
  • The exact etiology remains unknown, but associations include HLA-B51, heat shock protein 60, Th1 immune responses, and potential microbial triggers.

Purpose of the Study:

  • To review the updated Japanese diagnostic criteria for Behcet's disease (BD) to prevent overdiagnosis.
  • To highlight key diagnostic indicators and differential diagnoses for BD.
  • To summarize current and emerging therapeutic strategies for BD.

Main Methods:

  • Review of existing literature and diagnostic criteria for Behcet's disease.

Related Experiment Videos

  • Analysis of diagnostic criteria revisions in Japan (1987, 2003).
  • Discussion of laboratory findings (pathergy test, HLA-B51) and pathological evidence.

    • Main Results:

    • The 2003 revised Japanese criteria aim to improve BD diagnosis accuracy.
    • Differential diagnosis from conditions like Sweet's disease and Crohn's disease is crucial.
    • Newer treatments like anti-TNF antibodies and thalidomide show promise for severe BD cases.

    Conclusions:

    • Accurate diagnosis of Behcet's disease relies on updated criteria and careful exclusion of other conditions.
    • Emerging therapies offer new hope for managing severe BD manifestations.
    • Further research is essential for understanding BD etiology and developing novel treatments.